Main aim:
leverage the central Registry for gene and cellular therapy as a suitable data source for HTA.
Current status:
This Work Package is currently on hold.
EUnetHTA, the European Network for Health Technology Assessment, has given input in the revision of the EBMT Cellular Therapy form within WP1 on Data harmonization.